These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20627177)

  • 1. Prognostic value of cardiac troponins and natriuretic peptides in hospitalized nursing home residents.
    Aronow WS
    J Am Med Dir Assoc; 2010 Jul; 11(6):386-8. PubMed ID: 20627177
    [No Abstract]   [Full Text] [Related]  

  • 2. Excellence in acute cardiac care: an overview of the seminar proceedings.
    ; Thygesen K; Jaffe A; Apple F; Mockel M; Venge P; Plebani M; deFillipi C; Frye B; Wallseth A; Lindenau Stokfisch V
    Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(1 Suppl):1-16. PubMed ID: 25114329
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery.
    Fellahi JL; Hanouz JL; Le Manach Y; Gué X; Monier E; Guillou L; Riou B
    Anesthesiology; 2009 Aug; 111(2):250-7. PubMed ID: 19568166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular biomarkers in the ICU.
    Noveanu M; Mebazaa A; Mueller C
    Curr Opin Crit Care; 2009 Oct; 15(5):377-83. PubMed ID: 19606027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natriuretic peptide family as a "novel candidate marker" for the assessment of diagnosis, therapeutic response and prognosis in cardiovascular disease].
    Altekin E
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):452-3. PubMed ID: 18065352
    [No Abstract]   [Full Text] [Related]  

  • 6. Natriuretic peptides as markers of cardiovascular disease. Their use in diagnosis, prognosis and therapy.
    de Bold AJ
    Rev Fac Cien Med Univ Nac Cordoba; 2003; 60(1):43-8. PubMed ID: 16724441
    [No Abstract]   [Full Text] [Related]  

  • 7. Natriuretic peptides in acute chest pain and acute coronary syndrome: from pathophysiology to clinical and prognostic applications.
    Aspromonte N; Di Fusco SA; Latini R; Cruz DN; Masson S; Tubaro M; Palazzuoli A
    Coron Artery Dis; 2013 Jan; 24(1):33-9. PubMed ID: 23164752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and significance of detectable troponins as measured by highly sensitive assays in the general population.
    de Lemos JA; deFilippi CR
    Coron Artery Dis; 2013 Dec; 24(8):705-9. PubMed ID: 24201087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process.
    Perna ER; Címbaro Canella JP; Macin SM
    Minerva Cardioangiol; 2005 Dec; 53(6):523-35. PubMed ID: 16333236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Troponin elevation--differential diagnostic considerations and prognostic importance].
    Jensen JK; Mickley H
    Ugeskr Laeger; 2003 Apr; 165(15):1541-5. PubMed ID: 12715654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diseases from every organ system can raise cardiac troponin concentration.
    Goran KP
    Resuscitation; 2010 Jan; 81(1):128. PubMed ID: 19850396
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides: update on Peptide release, bioactivity, and clinical use.
    Richards AM
    Hypertension; 2007 Jul; 50(1):25-30. PubMed ID: 17452510
    [No Abstract]   [Full Text] [Related]  

  • 14. [Natriuretic peptides in clinical practice].
    Urek R; Cubrilo-Turek M
    Acta Med Croatica; 2008 Feb; 62(1):53-6. PubMed ID: 18365500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natriuretic peptides and cardiac resynchronization therapy].
    Michelucci A; Padeletti L; Giaccardi M; Abbate R
    G Ital Cardiol (Rome); 2006 Apr; 7(4):296-8. PubMed ID: 16700413
    [No Abstract]   [Full Text] [Related]  

  • 16. Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I.
    Venge P; Ohberg C; Flodin M; Lindahl B
    Am Heart J; 2010 Nov; 160(5):835-41. PubMed ID: 21095269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
    Searle J; Danne O; Müller C; Mockel M
    Minerva Cardioangiol; 2011 Jun; 59(3):203-23. PubMed ID: 21516070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin I elevation in hospitalized patients without acute coronary syndromes.
    Blich M; Sebbag A; Attias J; Aronson D; Markiewicz W
    Am J Cardiol; 2008 May; 101(10):1384-8. PubMed ID: 18471446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides: ready for prime-time in hypertension?
    Bricca G; Lantelme P
    Arch Cardiovasc Dis; 2011; 104(6-7):403-9. PubMed ID: 21798473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term biological variation in cardiac troponin I.
    Wu AH; Akhigbe P; Wians F
    Clin Biochem; 2012 Jul; 45(10-11):714-6. PubMed ID: 22449338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.